Muscle density is an independent risk factor of second hip fracture: a prospective cohort study.
Bone mineral density
Muscle density
Muscle size
Second hip fracture
Journal
Journal of cachexia, sarcopenia and muscle
ISSN: 2190-6009
Titre abrégé: J Cachexia Sarcopenia Muscle
Pays: Germany
ID NLM: 101552883
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
revised:
17
03
2022
received:
05
07
2021
accepted:
30
03
2022
pubmed:
17
4
2022
medline:
11
6
2022
entrez:
16
4
2022
Statut:
ppublish
Résumé
Patients with a first hip fracture are at high risk of fracturing their other hip. Despite this, preventive therapy is often not given. Because little is known about specific risk factors of a second hip fracture, we investigated the association with areal bone mineral density (aBMD), muscle size, and density. We also investigated whether muscle parameters predict the risk of a contralateral fracture independently of aBMD. Three groups were included, one without hip fracture (a subcohort of the China Action on Spine and Hip Status study), one with a first, and one with a second hip fracture. Subjects with fractures were recruited from the longitudinal Chinese Second Hip Fracture Evaluation (CSHFE). Computed tomography scans of CSHFE patients, which were obtained immediately following their first fracture, were used to measure cross-sectional area and density of the gluteus maximus (G.MaxM) and gluteus medius and minimus (G.Med/MinM) muscles. Computed tomography X-ray absorptiometry was used to measure aBMD of the contralateral femur. Median follow-up time to second fracture was 4.5 years. Cox proportional hazards models were used to compute hazard ratios (HR) of second hip fracture risk in subjects with a first hip fracture. Multivariate logistic regressions were used to compare odds ratios (OR) for the risk of a first and second hip fracture. Three hundred and one participants (68.4 ± 6.1 years, 64% female) without and 302 participants (74.6 ± 9.9 years, 71% female) with a first hip fracture were included in the analysis. Among the latter, 45 (79.2 ± 7.1 years) sustained a second hip fracture. ORs for first hip fracture were significant for aBMD and muscle size and density. ORs for a second fracture were smaller by a factor of 3 to 4 and no longer significant for femoral neck (FN) aBMD. HRs for predicting second hip fracture confirmed the results. G.Med/MinM density (HR, 1.68; CI, 1.20-2.35) and intertrochanter aBMD (HR, 1.62; CI, 1.13-2.31) were the most significant. FN aBMD was not significant. G.Med/MinM density remained significant for predicting second hip fracture after adjustment for FN (HR, 1.66; Cl, 1.18-2.30) or total hip aBMD (HR, 1.50; 95% Cl, 1.04-2.15). Density of the G.Med/MinM muscle is an aBMD independent predictor of the risk of second hip fracture. Intertrochanteric aBMD is a better predictor of second hip fracture than FN and total hip aBMD. These results may trigger a paradigm shift in the assessment of second hip fracture risk and prevention strategies.
Sections du résumé
BACKGROUND
Patients with a first hip fracture are at high risk of fracturing their other hip. Despite this, preventive therapy is often not given. Because little is known about specific risk factors of a second hip fracture, we investigated the association with areal bone mineral density (aBMD), muscle size, and density. We also investigated whether muscle parameters predict the risk of a contralateral fracture independently of aBMD.
METHODS
Three groups were included, one without hip fracture (a subcohort of the China Action on Spine and Hip Status study), one with a first, and one with a second hip fracture. Subjects with fractures were recruited from the longitudinal Chinese Second Hip Fracture Evaluation (CSHFE). Computed tomography scans of CSHFE patients, which were obtained immediately following their first fracture, were used to measure cross-sectional area and density of the gluteus maximus (G.MaxM) and gluteus medius and minimus (G.Med/MinM) muscles. Computed tomography X-ray absorptiometry was used to measure aBMD of the contralateral femur. Median follow-up time to second fracture was 4.5 years. Cox proportional hazards models were used to compute hazard ratios (HR) of second hip fracture risk in subjects with a first hip fracture. Multivariate logistic regressions were used to compare odds ratios (OR) for the risk of a first and second hip fracture.
RESULTS
Three hundred and one participants (68.4 ± 6.1 years, 64% female) without and 302 participants (74.6 ± 9.9 years, 71% female) with a first hip fracture were included in the analysis. Among the latter, 45 (79.2 ± 7.1 years) sustained a second hip fracture. ORs for first hip fracture were significant for aBMD and muscle size and density. ORs for a second fracture were smaller by a factor of 3 to 4 and no longer significant for femoral neck (FN) aBMD. HRs for predicting second hip fracture confirmed the results. G.Med/MinM density (HR, 1.68; CI, 1.20-2.35) and intertrochanter aBMD (HR, 1.62; CI, 1.13-2.31) were the most significant. FN aBMD was not significant. G.Med/MinM density remained significant for predicting second hip fracture after adjustment for FN (HR, 1.66; Cl, 1.18-2.30) or total hip aBMD (HR, 1.50; 95% Cl, 1.04-2.15).
CONCLUSIONS
Density of the G.Med/MinM muscle is an aBMD independent predictor of the risk of second hip fracture. Intertrochanteric aBMD is a better predictor of second hip fracture than FN and total hip aBMD. These results may trigger a paradigm shift in the assessment of second hip fracture risk and prevention strategies.
Identifiants
pubmed: 35429146
doi: 10.1002/jcsm.12996
pmc: PMC9178374
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1927-1937Subventions
Organisme : National Natural Science Foundation of China
ID : 81771831
Organisme : National Natural Science Foundation of China
ID : 81901718
Organisme : Beijing Hospitals Authority Clinical Medicine Development of Special Funding Support
ID : ZYLX202107
Organisme : Beijing Natural Science Foundation-Haidian Primitive Innovation Joint Fund
ID : L172019
Informations de copyright
© 2022 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders.
Références
JAMA Intern Med. 2021 Aug 1;181(8):1055-1063
pubmed: 34096979
Lancet. 2018 Feb 24;391(10122):741-747
pubmed: 29254858
Osteoporos Int. 2011 May;22(5):1277-88
pubmed: 21461721
J Bone Miner Res. 2010 Mar;25(3):513-9
pubmed: 20422623
J Bone Joint Surg Br. 1993 Sep;75(5):797-8
pubmed: 8376443
Osteoporos Int. 2015 Jul;26(7):1903-10
pubmed: 25910745
J Am Med Dir Assoc. 2021 Apr;22(4):751-759.e2
pubmed: 32768372
PLoS Med. 2020 Aug 6;17(8):e1003180
pubmed: 32760065
J Bone Miner Res. 2020 Jan;35(1):36-52
pubmed: 31538675
J Cachexia Sarcopenia Muscle. 2019 Jun;10(3):485-500
pubmed: 30993881
Calcif Tissue Int. 2012 Jan;90(1):14-21
pubmed: 22076525
Endocr Pract. 2020 May;26(Suppl 1):1-46
pubmed: 32427503
J Bone Miner Res. 2000 Apr;15(4):721-39
pubmed: 10780864
Quant Imaging Med Surg. 2018 Aug;8(7):667-672
pubmed: 30211034
Arch Osteoporos. 2017 Aug 15;12(1):72
pubmed: 28812206
J Bone Miner Res. 2007 Jun;22(6):825-31
pubmed: 17352651
J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):2259-2261
pubmed: 34904399
Injury. 2015 Nov;46(11):2206-11
pubmed: 26298023
Radiology. 2019 Feb;290(2):426-434
pubmed: 30457478
Bone. 2012 Jun;50(6):1343-50
pubmed: 22421579
Arch Intern Med. 2007 Oct 8;167(18):1971-6
pubmed: 17923597
J Cachexia Sarcopenia Muscle. 2020 Dec;11(6):1799-1812
pubmed: 32894000
Osteoporos Int. 2020 May;31(5):921-929
pubmed: 31802158
J Gerontol A Biol Sci Med Sci. 2014 Mar;69(3):346-53
pubmed: 23873945
Eur Heart J. 2014 Nov 7;35(42):2936-41
pubmed: 24711436
Bone. 2008 Apr;42(4):798-805
pubmed: 18234578
J Cachexia Sarcopenia Muscle. 2022 Jun;13(3):1927-1937
pubmed: 35429146
Ann Intern Med. 2017 Jun 6;166(11):818-839
pubmed: 28492856
Osteoporos Int. 2016 Mar;27(3):1137-1147
pubmed: 26415934
Osteoporos Int. 2020 Oct;31(10):1817-1828
pubmed: 32613411
Bone. 2020 Oct;139:115545
pubmed: 32730940
Bone. 1997 Mar;20(3):213-8
pubmed: 9071471
J Cachexia Sarcopenia Muscle. 2020 Jun;11(3):663-677
pubmed: 32091670